Rebalix
Logo iSharesiShares · sheet of 5 September 2026
ETF sheet · official issuer and register data

iShares NASDAQ 100 Swap UCITS ETF

N1UD · IE00074JV7J1 · USD · domicile Ireland
Equity · United States · Large & mid capSFDR art. 6
Index tracked: NASDAQ 100 Index
TER
0.20%+ trans. 0.00%
Fund size
1.4 bn EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Synthetic (swap)
Income
Distributingsemi-annual
Launch 11 Dec 2024 · costs from the KID as of 2 Sept 2026 · 281 securities held

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Share Class is a share class of a Fund which aims to achieve a return on your investment, through a combination of capital growth and income on the Fund’s assets, which reflects the net total return of the NASDAQ 100 Index, the Fund’s index (“Index”). The Share Class, via the Fund, is passively managed and invests in financial derivative instruments. In particular, it will enter into unfunded total return swaps, in order to achieve its investment objective. When using unfunded total return swaps, the Fund will invest its cash in global developed…

Performance since series start (in euro) — base 100

11 Dec 202431 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
2025202612975124
High 129 (30 Jun 2026) · low 75 (8 Apr 2025) · last 124. Past performance is not indicative of future results.

Returns in euro

1 year+27.0%
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+23.5%

Risk · 1 / 3 / 5 years

Volatility (ann.)19.43%19.43%
Max drawdown−11.93%−11.93%
Sharpe1.171.17
Sortino1.701.70
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · N1UD · IE00074JV7J11
RebalixN1UD · IE00074JV7J1 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+20.73%+20.77%−0.04%

Distributions · per share, in USD

Frequency: semi-annual · last 12 months: 0.02 USD (0.29% of NAV) · last ex-date 16 Apr 2026
YearPaymentsTotal (USD)Dividend yield
202610.01
202520.02+0.41%
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.

Holdings

Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 31 Aug 2026 · 281 securities · top-10 weight = 136.8%
Top holdingsWeight
NASDAQ 100 GROSS INDEX IN USD100.0%
TESLA INC4.6%
NVIDIA4.4%
AMAZON.COM INC4.4%
ADVANCED MICRO DEVICES4.3%
BERKSHIRE HATHAWAY INC CLASS B4.0%
MICRON TECHNOLOGY3.9%
SYNOPSYS3.9%
INTEL CORPORATION3.6%
ALPHABET CLASS A3.5%

Listing venues

ESMA register (FIRDS) and official exchange lists
No EU listing in the ESMA register.

Official documents

Clickable links in the PDF
KID · www.blackrock.com/it/investitori-privati/literature/kiid/eu-priips-ish
Factsheet · www.ishares.com/gls-download/literature/fact-sheet/n1ud-ishares-nasdaq
Prospectus · www.blackrock.com/it/investitori-privati/literature/prospectus/ishares
The live sheet, always up to date
rebalix.com/en/etf/IE00074JV7J1
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · N1UD · IE00074JV7J12